Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cybin Inc (NY: CYBN ) 8.840 -0.060 (-0.67%) Official Closing Price Updated: 8:00 PM EDT, Oct 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Cybin Inc < Previous 1 2 3 4 5 6 7 8 9 ... 38 39 Next > Cybin Announces Size and Pricing of Previously Announced Overnight Marketed Public Offering of Units August 01, 2023 From Cybin Inc. Via Business Wire Why TETRA Technologies Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket August 01, 2023 Gainers American Superconductor Corporation (NASDAQ: AMSC) shares surged 112.1% to $21.38 in pre-market trading. AMSC is expected to report first-quarter results on Aug. 9, 2023. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday August 01, 2023 It's time for a look at the biggest pre-market stock movers as we check out the latest news worth reading on Tuesday morning! Via InvestorPlace Analyst Expectations for Cybin's Future July 03, 2023 Via Benzinga Cybin: Q4 Earnings Insights June 27, 2023 Via Benzinga Cybin Announces Overnight Marketed Public Offering of Units July 31, 2023 From Cybin Inc. Via Business Wire InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Plans to Participate in Annual Canaccord Genuity Growth Conference July 27, 2023 Via Investor Brand Network Cybin to Participate in the Canaccord Genuity 43rd Annual Growth Conference July 27, 2023 From Cybin Inc. Via Business Wire InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), Global CRO Partner to Study, Develop CYB003 as Effective MDD Treatment July 26, 2023 Via Investor Brand Network Global Psychedelic Therapeutics Market Size Expected To Reach $13.29 Billion By The Year 2031 July 26, 2023 EQNX::TICKER_START (NYSE:CYBN),NEO:CYBN),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:SEEL),(OTCQX:NUMIF) EQNX::TICKER_END Via FinancialNewsMedia Cybin Partners With Worldwide Clinical Trials to Support Future Clinical Development of CYB003 in Major Depressive Disorder July 26, 2023 From Cybin Inc. Via Business Wire Cybin, Bright Minds And PharmAla: A Short Recap On Progress Within Clinical Trials July 24, 2023 Cybin One Steps Away From Complete Dosing Via Benzinga InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Completes Significant Milestone in Advancing CYB003 Towards Pivotal Studies July 24, 2023 Via Investor Brand Network Exposures Product Safety Cybin Announces Phase 2 Cohort 5 Dosing Completion of CYB003 in Major Depressive Disorder July 24, 2023 From Cybin Inc. Via Business Wire A Quantum Leap In Psychedelic Research: Study Shows Real-Time Brain Changes After Ketamine Use July 21, 2023 A newly published study shows that Kernel’s Flow technology system is in fact able to capture and analyze brain changes following the administration of a psychoactive substance. Via Benzinga Cybin Announces Publication of Sponsored Feasibility Study Validating Kernel’s Flow1 Neuroimaging Technology Measuring Psychedelic Effects on the Brain July 20, 2023 From Cybin Inc. Via Business Wire PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Results from ‘Groundbreaking’ Sponsored Study Measuring Psychedelic Effects July 20, 2023 Via Investor Brand Network InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Results from ‘Groundbreaking’ Sponsored Study Measuring Psychedelic Effects July 20, 2023 Via Investor Brand Network Kernel's Revolutionary Neuroimaging Technology, Flow1, Validated in Published Feasibility Study on Measuring Psychedelic Effects July 20, 2023 From Kernel Via Business Wire InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Shares Plans to Develop Scalable Psychedelic Facilitation Training Program July 12, 2023 Via Investor Brand Network Cybin Announces the Development of a Scalable Psychedelic Facilitation Training Program, EMBARKCT July 12, 2023 From Cybin Inc. Via Business Wire Why Caribou Biosciences Shares Are Trading Higher By Around 58%? Here Are Other Stocks Moving In Thursday's Session July 06, 2023 Gainers Caribou Biosciences, Inc. (NASDAQ: CRBU) shares jumped 58.1% to $6.45 after the company announced a $25 million equity investment from Pfizer. Via Benzinga Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More July 04, 2023 World's Largest Psychedelics Conference Boasts 12K Attendees Via Benzinga InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Names New COO, Announces Participation in Upcoming London Symposium June 30, 2023 Via Investor Brand Network Exposures Product Safety Cybin to Participate in PSYCH Symposium London 2023 June 30, 2023 From Cybin Inc. Via Business Wire Cybin Inc. Announces Appointment of Aaron Bartlone as Chief Operating Officer June 29, 2023 From Cybin Inc. Via Business Wire Cybin's FY2023 Financials, Guidance And Appointment Of Sanford R. Climan As Strategic Advisor June 28, 2023 Psychedelics biopharma company Cybin Inc. (NYSE: CYBN) shared its financial results for the fiscal year ended this March 31 as well as recent business highlights. Numbers show: Total cash of $12.5... Via Benzinga InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Releases FY 2023 Financial Report, Business Highlights June 28, 2023 Via Investor Brand Network Exposures Product Safety Cybin Inc. Reports Fiscal Year 2023 Financial Results and Recent Business Highlights June 27, 2023 From Cybin Inc. Via Business Wire InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Names Seasoned Veteran as Strategic Advisor June 27, 2023 Via Investor Brand Network < Previous 1 2 3 4 5 6 7 8 9 ... 38 39 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.